Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
185 hedge funds and large institutions have $1.85B invested in Impax Laboratories, Inc. in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 72 reducing their positions, and 25 closing their positions.
28% more capital invested
Capital invested by funds: $1.45B → $1.85B (+$402M)
16% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 25
2% more funds holding
Funds holding: 181 → 185 (+4)
8% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 72
32% less call options, than puts
Call options by funds: $3.56M | Put options by funds: $5.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$41.5M |
| 2 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$37.8M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$34.3M |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$26.6M |
| 5 |
NAP
New Amsterdam Partners
New York
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$27.6M |
| 2 |
Millennium Management
New York
|
-$22.8M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$13.2M |
| 4 |
D.E. Shaw & Co
New York
|
-$12.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.1M |
IPXL Hedge Fund Activity: Q2 2014 in Review
185 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q2 2014, worth a combined $1.85B — up 28% from $1.45B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new IPXL positions and 25 closed out — a net gain of 4 holders — while 66 added to existing stakes and 72 trimmed.
The largest buyer was Invesco, adding an estimated $41.5M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $27.6M sold.
- 185 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q2 2014, up from 181 in Q1 2014.
- Funds reported $1.85B of Impax Laboratories, Inc. stock for Q2 2014, up 28% quarter-over-quarter.
- 29 funds opened new Impax Laboratories, Inc. positions in Q2 2014 and 25 closed out, a net change of +4 holders.
- The largest Impax Laboratories, Inc. buyer in Q2 2014 was Invesco, an estimated $41.5M added.
- The largest Impax Laboratories, Inc. seller in Q2 2014 was Renaissance Technologies, an estimated $27.6M sold.
Based on aggregated 13F filings for Q2 2014.